Oral THC Abstinence Affected Mood, Sleep and Eating in a Residential Human Study

A residential study of marijuana smokers found abstinence-related changes in mood, sleep and eating after repeated oral THC. Tolerance during administration was selective: subjective effects weakened while food-intake and social-behavior effects persisted.

The study controlled repeated administration

Six men and six women participated in a 20-day residential protocol with active oral THC and placebo periods. THC was administered four times daily during two active periods. The lower doses discussed in the paper were lower than earlier high-dose research, not a claim that the regimen was low-risk or equivalent to an ordinary consumer dose.

Different effects did not become tolerant together

Active THC increased positive subjective ratings and food intake while reducing verbal interaction. Tolerance developed to subjective ratings but not to eating or social behavior in the reported comparisons. Reduced feelings of intoxication therefore did not imply disappearance of every observable effect.

Abstinence differed from the placebo baseline

During abstinence, anxiety, depressed-mood and irritability ratings increased. Reported sleep quantity and quality decreased, as did food intake. These were observations within an established-smoker sample and a controlled repeated-dose protocol, not estimates of withdrawal prevalence among all cannabis users.

The experiment supports dependence-related changes after repeated oral THC under specified conditions. It does not establish that everyone develops the same symptoms or severity. Its distinct value is the combined observation of selective tolerance during exposure and mood, sleep and dietary changes after active dosing ended.

Related: interpreting cannabis tolerance claims.

Research cited

Haney M; Ward AS; Comer SD; Foltin RW; Fischman MW. Abstinence symptoms following oral THC administration to humans. Psychopharmacology (1999). doi:10.1007/s002130050848. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

An experimental THC study found lower adrenal-medullary catecholamine stores after acute exposure without a statistically significant decline in a key synthesis enzyme. The changes disappeared with repeated treatment, while circulating hormones followed partly different patterns. Tissue content and enzyme activity were separate measures Acute THC decreased adrenal norepinephrine and epinephrine…

Spread the love

Read Article: Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Some experimental rimonabant analogues produced cannabinoid-like effects in mouse tests but did not reproduce THC's learned drug cue. Other comparisons also separated the compounds from THC, cautioning against equating a similar outward profile with the same pharmacology. Behavioral similarity was only the starting point O-6629 and O-6658 produced dose-dependent effects…

Spread the love

Read Article: Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

A mouse study detected substantial THC behavioral tolerance without significant changes in whole-brain receptor binding or mRNA. The result limits a simple whole-brain explanation while leaving regional or functional changes unresolved. Behavior and biochemical assays were different endpoints Mice received THC twice daily for six and a half days. Testing…

Spread the love

Read Article: Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us